{"id":87882,"date":"2021-11-29T03:00:45","date_gmt":"2021-11-29T02:00:45","guid":{"rendered":"https:\/\/www.cde.ual.es\/?p=87882"},"modified":"2021-11-26T13:56:58","modified_gmt":"2021-11-26T12:56:58","slug":"new-future-proof-eu-pharmaceutical-policy","status":"publish","type":"post","link":"https:\/\/www.cde.ual.es\/en\/new-future-proof-eu-pharmaceutical-policy\/","title":{"rendered":"New future-proof EU pharmaceutical policy"},"content":{"rendered":"
\"\"<\/a>
Pharmaceutical technician in sterile environment working in the production of pills in the pharmacy factory<\/figcaption><\/figure>\n
\n
\n
\n

Affordable medicines, preventing shortages and a climate-neutral industry – Parliament presses for a new EU pharmaceutical policy.<\/p>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n

During the plenary session in November 2021, the\u00a0European Parlimanet set out a series of recommendations<\/a>\u00a0for the update of the EU’s pharmaceutical legislation.<\/p>\n

Faster access<\/h3>\n
\n

In 2019, the European Medicines Agency (EMA) authorised 103 orphan drugs – which are drugs to treat rare medical conditions – but only half of them reached the market, with an average delay of two years. This is just one of the issues raised in a report about EU pharmaceutical policy<\/a>. To solve this problem MEPs called for shorter approval times by national agencies and alignment with the European Medicines Agency to ensure rapid and equal access to medicines across the EU.<\/p>\n

Read more about <\/em>EU public health measures<\/em><\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n

Shortages of medicines<\/h2>\n

<\/h3>\n

The Covid-19 crisis has highlighted shortages of medicines and medical equipment, putting patients at risk and national health systems under pressure. Parliament called on the European Commission to address the root causes of shortages and propose sustainable solutions including the timely entry into the market of generic and biosimilar medicines in order to ensure patients have access to safe and affordable drugs.<\/p>\n

<\/h3>\n

Find more about\u00a0<\/em>medicine shortages and Parliament\u2019s solutions<\/em><\/a><\/p>\n

Environmentally friendly pharmaceutical industry<\/h3>\n

Parliament also said the pharmaceutical industry should become environmentally friendly and product life cycles should be climate-neutral. The Parliament stressed the need to strengthen EU manufacturing and supply resilience and to increase transparency on prices and public funding for research and development.<\/p>\n

\nMEPs recommend coordinated awareness campaigns on\u00a0antimicrobial resistance<\/a>; and developing adequate capacity for the sustainable production of active substances, raw materials and medicines in order to reduce dependence on external sources.<\/p>\n

The report calls on the Commission to fully implement the Clinical Trials Regulation to facilitate the launch of large clinical trials carried out in a harmonised and coordinated manner at EU level.<\/p>\n

More information:<\/h3>\n

European Parliamen<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Affordable medicines, preventing shortages and a climate-neutral industry – Parliament presses for a new EU pharmaceutical policy. During the plenary session in November 2021, the\u00a0European Parlimanet set out a series of recommendations\u00a0for the update of the EU’s pharmaceutical legislation. Faster access In 2019, the European Medicines Agency (EMA) authorised 103 orphan drugs – which are […]<\/p>\n","protected":false},"author":101011,"featured_media":87883,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[4093,346,4094,4092],"tags":[4689,2033],"class_list":{"0":"post-87882","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-diseases","8":"category-eu-news","9":"category-farmac","10":"category-health","11":"tag-pharmaceutical-industry","12":"tag-public-health","13":"entry"},"acf":[],"yoast_head":"\nNew future-proof EU pharmaceutical policy | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cde.ual.es\/?p=87886\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New future-proof EU pharmaceutical policy | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"og:description\" content=\"Affordable medicines, preventing shortages and a climate-neutral industry – Parliament presses for a new EU pharmaceutical policy. During the plenary session in November 2021, the\u00a0European Parlimanet set out a series of recommendations\u00a0for the update of the EU’s pharmaceutical legislation. Faster access In 2019, the European Medicines Agency (EMA) authorised 103 orphan drugs – which are […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cde.ual.es\/?p=87886\" \/>\n<meta property=\"og:site_name\" content=\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-29T02:00:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/11\/20211125PHT18123_original.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1800\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"BECA 2 CDE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:site\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BECA 2 CDE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886\"},\"author\":{\"name\":\"BECA 2 CDE\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/ee46ebc19edfa19598c02cff83335acc\"},\"headline\":\"New future-proof EU pharmaceutical policy\",\"datePublished\":\"2021-11-29T02:00:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886\"},\"wordCount\":344,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/20211125PHT18123_original.jpg\",\"keywords\":[\"pharmaceutical industry\",\"public health\"],\"articleSection\":[\"Diseases\",\"EU News\",\"Farmaceutical\",\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886\",\"name\":\"New future-proof EU pharmaceutical policy | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/20211125PHT18123_original.jpg\",\"datePublished\":\"2021-11-29T02:00:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886#primaryimage\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/20211125PHT18123_original.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/20211125PHT18123_original.jpg\",\"width\":1800,\"height\":1200,\"caption\":\"Pharmaceutical technician in sterile environment working on production of pills at pharmacy factory\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/?p=87886#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU News\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"New future-proof EU pharmaceutical policy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"name\":\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"description\":\"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"alternateName\":\"CDE Almer\u00eda\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cde.ual.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\",\"name\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"width\":1400,\"height\":300,\"caption\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/cdeuniversidadalmeria\\\/\",\"https:\\\/\\\/x.com\\\/cdeualmeria\",\"https:\\\/\\\/www.tiktok.com\\\/@cdealmeria\",\"https:\\\/\\\/www.instagram.com\\\/cdealmeria\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/cde-almera-812b26a9\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/ee46ebc19edfa19598c02cff83335acc\",\"name\":\"BECA 2 CDE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g\",\"caption\":\"BECA 2 CDE\"},\"sameAs\":[\"http:\\\/\\\/www.cdealmeria.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New future-proof EU pharmaceutical policy | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cde.ual.es\/?p=87886","og_locale":"en_US","og_type":"article","og_title":"New future-proof EU pharmaceutical policy | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","og_description":"Affordable medicines, preventing shortages and a climate-neutral industry – Parliament presses for a new EU pharmaceutical policy. During the plenary session in November 2021, the\u00a0European Parlimanet set out a series of recommendations\u00a0for the update of the EU’s pharmaceutical legislation. Faster access In 2019, the European Medicines Agency (EMA) authorised 103 orphan drugs – which are […]","og_url":"https:\/\/www.cde.ual.es\/?p=87886","og_site_name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","article_publisher":"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","article_published_time":"2021-11-29T02:00:45+00:00","og_image":[{"width":1800,"height":1200,"url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/11\/20211125PHT18123_original.jpg","type":"image\/jpeg"}],"author":"BECA 2 CDE","twitter_card":"summary_large_image","twitter_creator":"@cdeualmeria","twitter_site":"@cdeualmeria","twitter_misc":{"Written by":"BECA 2 CDE","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cde.ual.es\/?p=87886#article","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/?p=87886"},"author":{"name":"BECA 2 CDE","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/ee46ebc19edfa19598c02cff83335acc"},"headline":"New future-proof EU pharmaceutical policy","datePublished":"2021-11-29T02:00:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cde.ual.es\/?p=87886"},"wordCount":344,"commentCount":0,"publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"image":{"@id":"https:\/\/www.cde.ual.es\/?p=87886#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/11\/20211125PHT18123_original.jpg","keywords":["pharmaceutical industry","public health"],"articleSection":["Diseases","EU News","Farmaceutical","Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.cde.ual.es\/?p=87886#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.cde.ual.es\/?p=87886","url":"https:\/\/www.cde.ual.es\/?p=87886","name":"New future-proof EU pharmaceutical policy | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cde.ual.es\/?p=87886#primaryimage"},"image":{"@id":"https:\/\/www.cde.ual.es\/?p=87886#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/11\/20211125PHT18123_original.jpg","datePublished":"2021-11-29T02:00:45+00:00","breadcrumb":{"@id":"https:\/\/www.cde.ual.es\/?p=87886#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cde.ual.es\/?p=87886"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/?p=87886#primaryimage","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/11\/20211125PHT18123_original.jpg","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/11\/20211125PHT18123_original.jpg","width":1800,"height":1200,"caption":"Pharmaceutical technician in sterile environment working on production of pills at pharmacy factory"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cde.ual.es\/?p=87886#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.cde.ual.es\/en\/"},{"@type":"ListItem","position":2,"name":"EU News","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/"},{"@type":"ListItem","position":3,"name":"New future-proof EU pharmaceutical policy"}]},{"@type":"WebSite","@id":"https:\/\/www.cde.ual.es\/#website","url":"https:\/\/www.cde.ual.es\/","name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","description":"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda","publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"alternateName":"CDE Almer\u00eda","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cde.ual.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cde.ual.es\/#organization","name":"Centro de Documentaci\u00f3n Europea de Almer\u00eda","url":"https:\/\/www.cde.ual.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","width":1400,"height":300,"caption":"Centro de Documentaci\u00f3n Europea de Almer\u00eda"},"image":{"@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","https:\/\/x.com\/cdeualmeria","https:\/\/www.tiktok.com\/@cdealmeria","https:\/\/www.instagram.com\/cdealmeria\/","https:\/\/www.linkedin.com\/in\/cde-almera-812b26a9\/"]},{"@type":"Person","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/ee46ebc19edfa19598c02cff83335acc","name":"BECA 2 CDE","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g","caption":"BECA 2 CDE"},"sameAs":["http:\/\/www.cdealmeria.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/87882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/users\/101011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/comments?post=87882"}],"version-history":[{"count":0,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/87882\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media\/87883"}],"wp:attachment":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media?parent=87882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/categories?post=87882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/tags?post=87882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}